Subcutaneous C1 Inhibitor for Long-term Prophylaxis of Hereditary Angioedema: A Real-life Experience

J Investig Allergol Clin Immunol. 2024 Jun 17;34(3):198-199. doi: 10.18176/jiaci.0948. Epub 2023 Sep 5.

Authors

Affiliations

¹ National Angioedema Reference Unit, Allergology Department, Virgen del Rocío University Hospital, Seville, Spain.
² Immunology Department, Virgen del Rocío University Hospital, Seville, Spain.
³ Pediatric Allergology Unit, Allergology Department, Donostia University Hospital, Donostia, Spain.
⁴ Allergology Unit, San Cecilio University Hospital, Granada, Spain.
⁵ CSL Behring España S.A., Barcelona, Spain.
⁶ Ampersand Consulting, Barcelona, Spain.

PMID: 37796634
DOI: 10.18176/jiaci.0948

No abstract available

Keywords: C1 esterase inhibitor; Hereditary angioedema; Subcutaneous replacement therapy.

MeSH terms

Adult
Angioedemas, Hereditary* / drug therapy
Angioedemas, Hereditary* / prevention & control
Complement C1 Inhibitor Protein* / administration & dosage
Complement C1 Inhibitor Protein* / therapeutic use
Female
Humans
Injections, Subcutaneous
Male
Middle Aged

Substances

Complement C1 Inhibitor Protein